COMMUNIQUÉS West-GlobeNewswire

Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors
30/04/2026
Nelson Joins as the Company Builds the Leadership Infrastructure for Its Next Phase SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence [...]
Oncotelic Therapeutics Advances Toward Commercial Launch of AI-Enabled Robotics Platform Following Integration of 28 Million Scientific Abstracts
30/04/2026
LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB: OTLC), a clinical-stage biotechnology company focused on oncology and AI-driven solutions, [...]
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
30/04/2026
In-Vivo Ovine Study Demonstrates Sustained Performance Of Company’s Continuous Blood Glucose Monitoring (CBGM) Technology Over 240 Days, Reinforces Path to Key IDE Submission RUTHERFORD, N.J., April 30, 2026 (GLOBE [...]
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
30/04/2026
The listing on one of the world’s largest global cryptocurrency exchanges expands market access and secondary liquidity for Enlivex’s primary digital treasury asset Nes-Ziona, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- [...]
Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT)
30/04/2026
RICHMOND, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted three [...]
Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations
30/04/2026
DENVER, April 30, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com )- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or the “Company”), a leading developer of recombinant spider silk-based fibers, has achieved [...]
Centre for Neuro Skills CEO David Harrington Joins Brain to Brain Podcast to Discuss the Science of Recovery, Advocacy for Brain Injury Care and Why It Is Never Too Late
30/04/2026
Brain injury rehabilitation leader shares his personal story, CNS’s recovery-focused philosophy and the real barriers patients face in accessing the care they need BAKERSFIELD, Calif., April 30, 2026 (GLOBE NEWSWIRE [...]
YouthCommerce Unveils PhiFlow: A Revolutionary Operating Standard for Clinics
30/04/2026
PhiFlow Aims to Liberate Clinics from the Constraints of Paid Advertising Varsseveld, GELDERLAND, April 30, 2026 (GLOBE NEWSWIRE) -- YouthCommerce today launched PhiFlow , a growth-governance operating standard built [...]
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
30/04/2026
SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics (Nasdaq: PLRX) today announced the dosing of the first participant in the FORTIFY Phase 1b open-label indication expansion clinical [...]
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
30/04/2026
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight ® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision [...]
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
30/04/2026
NewcelX and Eledon Pharmaceuticals are collaborating to advance one of the few scalable approaches to a potential functional cure in Type 1 Diabetes, NCEL-101, as the flagship program and key long-term value driver [...]
Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
30/04/2026
Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced environmental impact. Through its global access to medicines programs, Teva reached [...]
Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment
30/04/2026
Appointment signals next phase of expansion for HIFU-based prostate care as demand grows for non-invasive, function-preserving treatment options CHARLOTTE, N.C., April 30, 2026 (GLOBE NEWSWIRE) -- Sonablate, a medical [...]
TimelyCare Expands Its Basic Needs Service to Help Colleges Better Support Student Retention
30/04/2026
Expanded offerings introduce Basic Needs Navigate and Basic Needs Connect, giving colleges and universities more flexible ways to deliver coordinated support at scale Fort Worth, TX, April 30, 2026 (GLOBE NEWSWIRE) -- [...]
Psychemedics Releases 2026 Workforce Insights Report
30/04/2026
New Data Highlights Shifting Drug Trends, Industry Risk Patterns, and the Growing Importance of Long-Window Testing DALLAS, April 30, 2026 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing [...]
A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine
30/04/2026
Supports scientific development and laboratory testing to advance pharmacogenomics deployment across Japan TOKYO, April 30, 2026 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare [...]
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
30/04/2026
ASHBURN, Va., April 30, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms
30/04/2026
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized [...]
Precision Neuroscience™ Partners With UChicago Medicine Researchers to Advance Brain–Computer Interface Research
30/04/2026
The collaboration expands Precision's clinical research network, deepening investigation into AI-driven neural cursor control and neuroprosthetics NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience [...]

Pages